Skip to main content
Glynn Weldon Gilcrease
( out of 813 reviews )

Glynn Weldon Gilcrease, MD

Languages spoken: English, Spanish

Clinical Locations

Primary Location

Huntsman Cancer Institute - Cancer Hospital South

Clinic 3A, Gastrointestinal
1950 Circle of Hope
Salt Lake City , UT 84112

Dr. G. Weldon Gilcrease, MD is an Associate Professor in the Oncology Division at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI) investigator. He specializes in gastrointestinal cancers and patients enrolled in early phase trials. Dr. Gilcrease is also the Program Director for the Hematology/Oncology Fellowship program at the University of Utah School of Medicine and a Huntsman Cancer Institute (HCI).

Dr. Gilcrease focuses on early phase clinical trials and drug development. He is involved in preclinical research and Phase I/II trials for patients affected with inoperable colorectal cancer. His research entails exploiting important pathways that drive cancer, including the beta-catenin pathway in colorectal cancer. He hopes to bring novel and targeted therapies into the clinic to benefit patients.

Dr. Gilcrease has been at the University of Utah since 2009. He completed a hematology/oncology fellowship at the University of Utah and HCI where he was awarded the Outstanding Fellow Teaching Award in 2011. Prior to that he completed his residency at Scripps Mercy Hospital in San Diego, CA where he received the Outstanding Resident Award for his medical care and dedication to learning and teaching. He served as Chief Resident after completing his residency. He earned his medical degree from the University of Arizona.

Board Certification

American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners

Patient Rating

Patients consistently report that Dr. Gilcrease is knowledgeable, thorough, and professional, explaining diagnoses and treatment options in clear, understandable terms. Reviewers emphasize his caring, personable manner—listening closely, answering questions patiently, and helping patients feel comfortable and supported throughout care. Several comments also note confidence in his clinical judgment and praise the professionalism and friendliness of his care team.

Generated via Patient Reviews

4.9 /5
( out of 813 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.


May 17, 2026
HUNTSMAN CANCER CENTER

Dr Gilcrease has my best interest at hand. He has done research in the cancer field and keeps my condition in mind. His recommendations have helped so far.

Apr 27, 2026
FARMINGTON HEALTH CENTER

Doctor Gilcrease was wonderful he took his time, didn't race he explains things to me. So I understood it, he answered all my questions from me. And my family, he wasn't rushing me and his staff was wonderful. Also, he made me feel very comfortable and very upfront about things.

Apr 15, 2026
HUNTSMAN CANCER CENTER

I was with him for a moment. I still have a test to go through. We will update later.

Apr 09, 2026
HUNTSMAN CANCER CENTER

Very nice and easy to understand what he was telling us

Apr 08, 2026
HUNTSMAN CANCER CENTER

Amazing and compassionate doctor.

Mar 04, 2026
HUNTSMAN CANCER CENTER

I've said it before'.Fantastic doctor! I'm so glad I've got him on my side!!

Feb 25, 2026
HUNTSMAN CANCER CENTER

Very good

Feb 25, 2026
HUNTSMAN CANCER CENTER

He is always willing to listen and give caring considerate advice.

Feb 12, 2026
HUNTSMAN CANCER CENTER

Tells me like it is

Feb 11, 2026
HUNTSMAN CANCER CENTER

Dr. Gilcrease has always been great

Feb 11, 2026
HUNTSMAN CANCER CENTER

Dr. Gilcrease has always left me feeling safe, secure, and well cared for. Him and his colleagues have made the healthcare process a joy, which is very surprising given the severity of my diagnosis. A great doctor in a great place full of other great people.

Feb 06, 2026
HUNTSMAN CANCER CENTER

Good doctor. Clear straight forward.

Feb 06, 2026
HUNTSMAN CANCER CENTER

Excellent care from a professional expert. Made a scary and apprehensive visit very comfortable.

Feb 02, 2026
HUNTSMAN CANCER CENTER

Very helpful

Jan 17, 2026
HUNTSMAN CANCER CENTER

Very professional and extremely knowable about my type of cancer. Gave me very good information about what to do to take on this type of cancer. Very friendly and made me feel very comfortable asking questions about treatments, no matter how dumb they were. I really liked it when he told me to get back to pumping iron and that it was ok to go to a gym again and lead a normal life. Plus, he had on wizard shoes. Outstanding cancer doctor!

Dec 31, 2025
HUNTSMAN CANCER CENTER

Dr. Gilcrease is an incredible doctor. He's knowledgeable, personable and caring. More than anything, he continually gives me hope.

Nov 28, 2025
HUNTSMAN CANCER CENTER

Absolutely superb doctor! Caring, knowledgeable, personable¿..really cares about his patients!!

Nov 23, 2025
FARMINGTON HEALTH CENTER

Dr Gilcrease is very knowledgeable. He looks at you eye to eye and not at the computer while he communicates with you. He makes notes for you to remember your conversation and care plan and gives them to you! I was so impressed by his bedside manner.

Nov 21, 2025
FARMINGTON HEALTH CENTER

Listens well, offers different treatment options and lets you do what you think is the best treatment for you even if it means no treatment as in my case.

Nov 20, 2025
HUNTSMAN CANCER CENTER

Asks if I have questions and concerns about my treatment Great Guy along with the team

Nov 12, 2025
HUNTSMAN CANCER CENTER

They were very informative, attentive, and answered all questions. Very friendly.

Nov 08, 2025
HUNTSMAN CANCER CENTER

Dr Gilcrease and his team at the liver clinic have been excellent to work with. They have treated me well and with great success.

Nov 03, 2025
FARMINGTON HEALTH CENTER

Dr. Gilcrease is outstanding. He listens to your concerns about treatments and is always there to answer any questions that you might have. He and his staff are friendly and very caring.

Nov 01, 2025
HUNTSMAN CANCER CENTER

Exelent!!

Oct 30, 2025
HUNTSMAN CANCER CENTER

Excellent oncologist!

Oct 25, 2025
HUNTSMAN CANCER CENTER

Awesome

Oct 15, 2025
HUNTSMAN CANCER CENTER

Great doctor!!

Oct 15, 2025
HUNTSMAN CANCER CENTER

Very knowledgeable and very caring about the disease that I had I'm very happy with him great guy!!!

Oct 14, 2025
HUNTSMAN CANCER CENTER

We had a great initial meeting with Dr. Baker. Do not hesitate to engage him as your provider.

Oct 06, 2025
HUNTSMAN CANCER CENTER

ok I guess, do not remember.

Oct 04, 2025
HUNTSMAN CANCER CENTER

Dr Gilcrease is very professional while being friendly and courteous. He is easy to talk to and listens attentively

Oct 01, 2025
HUNTSMAN CANCER CENTER

Best experience ever!

Sep 20, 2025
HUNTSMAN CANCER CENTER

His understanding of the needed treatment actually changed the planned treatment from my local Dr. From one set of drugs to another that is less brutal.

Aug 15, 2025
HUNTSMAN CANCER CENTER

He explained everything to me and in a way where I will understand him and what he's saying to me very good

Jul 19, 2025
HUNTSMAN CANCER CENTER

Incredibly competent and thoughtful dealing with a complex situation and treatment plan

Jul 18, 2025
HUNTSMAN CANCER CENTER

Dr. Gilcrease is by far the best. He truly cares about his patients. He takes time to go over everything and is genuinely a friendly doctor. Thank you Dr. Gilcrease for making [NAME REMOVED]'s cancer journey so much better!

Jul 10, 2025
HUNTSMAN CANCER CENTER

a very excellent physician

Jun 26, 2025
HUNTSMAN CANCER CENTER

Good [TRANSLATED]

May 26, 2025
HUNTSMAN CANCER CENTER

I feel well cared for by Dr Gilcrease and his staff. They are very professional and friendly.

May 21, 2025
HUNTSMAN CANCER CENTER

Carrington and knowledgeable

May 14, 2025
FARMINGTON HEALTH CENTER

A great physician, listens and actually engages in the conversation with you. I actually enjoy speaking with him, he is kind, professional and just an all round nice person. I trust him.

May 11, 2025
FARMINGTON HEALTH CENTER

Dr Gilcrease has a fine manner and intellect along with a good memory. HeÕs on task about my situation/health and helpful with what would be the next steps. IÕve appreciated his experience and educationÉ for sure. Lucky Me.

Apr 10, 2025
HUNTSMAN CANCER CENTER

GREAT EXPERIENCE EVERY TIME

Apr 09, 2025
HUNTSMAN CANCER CENTER

I trust him with my medical decisions

Mar 28, 2025
HUNTSMAN CANCER CENTER

Very kind and told me what I had to do [TRANSLATED]

Mar 26, 2025
HUNTSMAN CANCER CENTER

Superb doctor! Can't say enough good about him!

Mar 25, 2025
HUNTSMAN CANCER CENTER

addressed the medical issues

Mar 01, 2025
HUNTSMAN CANCER CENTER

He is great!

Feb 28, 2025
HUNTSMAN CANCER CENTER

Very helpful and informative. Always very compassionate and understanding.

Feb 16, 2025
HUNTSMAN CANCER CENTER

Fantastic!

Feb 02, 2025
HUNTSMAN CANCER CENTER

Good explanation and professional.

Jan 17, 2025
HUNTSMAN CANCER CENTER

Dr Gilcrease is very knowledgeable and professional. He shows that he cares

Jan 17, 2025
HUNTSMAN CANCER CENTER

Dr. Gilcrease is patient and cares deeply about your individual care needs. He is very personable and takes the time to really get to know you and develop the best treatment options.

Jan 16, 2025
HUNTSMAN CANCER CENTER

Exceptional doctor!

Jan 16, 2025
HUNTSMAN CANCER CENTER

Direct to the point knew what he was talking about

Jan 16, 2025
HUNTSMAN CANCER CENTER

Very impressive with his knowledge of performing the y90 procedure!

Jan 01, 2025
HUNTSMAN CANCER CENTER

Exceptionally good doctor. Caring, personable, knowledgeable. I can't say enough about how good Dr. Gilcrease is! I am so glad he is my oncologist.

Dec 26, 2024
HUNTSMAN CANCER CENTER

Dr. Gilcrease is a true professional in his field and he has a passion for his craft and as a patient, you could not ask for a better Doctor to be on your side during treatment and diagnosis!

Dec 25, 2024
HUNTSMAN CANCER CENTER

Compassionate and caring

Dec 23, 2024
HUNTSMAN CANCER CENTER

My doctor Glynn W Gilcreas is very caring and supportive and helpful always .I am lucky to have him my doctor..he was amazing and wonderful.

Dec 17, 2024
HUNTSMAN CANCER CENTER

Dr. Gilcrease, was very good at explaining things and answering questions. I liked his communication skills.

Dec 15, 2024
HUNTSMAN CANCER CENTER

The doctor explained things even I could understand what he was talking about

Dec 10, 2024
HUNTSMAN CANCER CENTER

I like him and his entire team

Nov 22, 2024
HUNTSMAN CANCER CENTER

He was very caring and awesome doctor.

Nov 20, 2024
HUNTSMAN CANCER CENTER

I was very impressed with the understanding and concern he showed for my condition.

Nov 17, 2024
FARMINGTON HEALTH CENTER

Dr Gilcrease is a great oncologist. Studies your situation throughly before deciding what route to take. I am thankful for him.

Nov 10, 2024
HUNTSMAN CANCER CENTER

I feel very comfortable and confident in Dr. Gilcrease's care.

Oct 30, 2024
HUNTSMAN CANCER CENTER

Excellent Doctor

Oct 30, 2024
FARMINGTON HEALTH CENTER

DR GILCREASE IS A VERY FRIENDLY AND DOWN TO EARTH PERSON. HE CARES ABOUT HIS PATIENTS, LISTENS TO THEM AND EXPLAINS TREATMENT PLANS AND PROCEDURES IN AN EASILY UNDERSTANDABLE MANNER. ALTHOUGH I HAVE AN INCURABLE DISEASE, DR GILCREASE HAS INCREASED MY CONFIDENCE IN FIGHTING IT AND MAINTAINING A GOOD QUALITY OF LIFE WHILE DOING SO.

Oct 29, 2024
HUNTSMAN CANCER CENTER

Dr. Gilcrease is concerned with the patient's specific issues. He has an intelligent approach and he's using the most up-to-date information to resolve the cancer issue. I am very comfortable relying on his plan and my cooperation to follow his instructions to cure my cancer! He's thorough, knowledgeable, connected to the patient, has genuine concern for the patient & delivers professional care.

Oct 20, 2024
HUNTSMAN CANCER CENTER

Very thorough in examination, questions and explanation of issues.

Oct 16, 2024
HUNTSMAN CANCER CENTER

Great doctor


Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

Board Certification and Academic Information

Academic Departments Internal Medicine -Professor (Clinical)
Academic Divisions Oncology
Board Certification
American Board of Internal Medicine (Sub: Medical Oncology)
National Board of Medical Examiners

Education history

Fellowship Arizona Center for Integrative Medicine Fellow
Fellowship Hematology and Oncology - University of Utah Fellow
Chief Resident Scripps Mercy Hospital Chief Medical Resident
Internship/Residency Scripps Mercy Hospital Intern/Resident
Professional Medical Medicine - The University of Arizona College of Medicine M.D.
Undergraduate Spanish, Summa Cum Laude - The University of Arizona, Tucson B.A.
Undergraduate Mathematics & Computer Science, Summa Cum Laude with Honors: Honors Thesis in Mathematics Titled Young Tableaux and Semi-Invariance of Symmetric Groups - The University of Arizona, Tucson B.S.

Selected Publications

Journal Article

  1. Geranios KC, Littau MJ, Park SS, Baker TB, Gilcrease GW, Cizman Z, Smith T, Baker MS (2024). Localized hepatocellular carcinoma: Is liver-directed therapy alone as efficacious as surgical resection? Surgery, 179, 108939.
  2. Gumbleton M, Allan S, Conway H, Boucher K, Marvin J, Hawks J, Burnett W, Van Brocklin M, Whisenant J, Gilcrease G, Gupta S (2023). A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE). BMC Res Notes, 16(1), 16.
  3. Pauley K, Koptiuch C, Greenberg S, Kohlmann W, Jeter J, Colonna S, Werner T, Kinsey C, Gilcrease G, Weis J, Whisenant J, Florou V, Garrido-Laguna I (2022). Discrepancies between tumor genomic profiling and germline genetic testing. ESMO Open, 7(4), 100526.
  4. Martin DB, Stetson PD, Gilcrease GW, Stillman RC, Sugalski JM, Skinner J, Levy M (2021). Preferences in Oncology History Documentation Styles Among Clinical Practitioners. JCO Oncol Pract, 18(1), e1-e8.
  5. Martin DB, Stetson PD, Gilcrease GW, Stillman RC, Sugalski JM, Skinner J, Levy M (2021). Preferences in Oncology History Documentation Styles Among Clinical Practitioners. JCO Oncol Pract, 18(1), OP2000756.
  6. Florou V, Nevala-Plagemann C, Whisenant J, Maeda P, Gilcrease GW, Garrido-Laguna I (2021). Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib. J Natl Compr Canc Netw, 19(5), 478-482.
  7. Wells SM, Boothe D, Ager BJ, Tao R, Gilcrease GW 3rd, Lloyd S (2020). Analysis of Nonsurgical Treatment Options for Metastatic Rectal Cancer. Clin Colorectal Cancer, 19(2), 91-99.e1.
  8. Nevala-Plagemann C, Moser J, Gilcrease GW, Garrido-Laguna I (2019). Survival of patients with metastatic HER2 positive gastro-oesophageal cancer treated with second-line chemotherapy plus trastuzumab or ramucirumab after progression on front-line chemotherapy plus trastuzumab. ESMO Open, 4(4), e000539.
  9. Weldon Gilcrease G, Stenehjem DD, Wade ML, Weis J, McGregor K, Whisenant J, Boucher KM, Thorne K, Orgain N, Garrido-Laguna I, Sharma S (2018). Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer. Invest New Drugs, 37(3), 482-489.
  10. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2019). Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med, 25(4), 620-627.
  11. Lloyd S, Baraghoshi D, Tao R, Garrido-Laguna I, Gilcrease GW 3rd, Whisenant J, Weis JR, Scaife C, Pickron TB, Huang LC, Monroe MM, Abdelaziz S, Fraser AM, Smith KR, Deshmukh V, Newman M, Rowe KG, Snyder J, Samadder NJ, Hashibe M (2019). Mental Health Disorders are More Common in Colorectal Cancer Survivors and Associated With Decreased Overall Survival. Am J Clin Oncol, 42(4), 355-362.
  12. Samadder NJ, Smith KR, Hanson H, Pimentel R, Wong J, Boucher K, Akerley W, Gilcrease G, Ulrich CM, Burt RW, Curtin K (2016 Mar). Familial Risk in Patients With Carcinoma of Unknown Primary. JAMA Oncol, 2(3), 340-346.
  13. Soldi R, Horrigan SK, Cholody MW, Padia J, Sorna V, Bearss J, Gilcrease G, Bhalla K, Verma A, Vankayalapati H, Sharma S (2015). Design, Synthesis, and Biological Evaluation of a Series of Anthracene-9,10-dione Dioxime β-Catenin Pathway Inhibitors. J Med Chem, 58(15), 5854-62.
  14. Ettinger DS, Handorf CR, Agulnik M, Bowles DW, Cates JM, Cristea M, Dotan E, Eaton KD, Fidias PM, Gierada D, Gilcrease GW, Godby K, Iyer R, Lenzi R, Phay J, Rashid A, Saltz L, Schwab RB, Shulman LN, Smerage JB, Stevenson MM, Varadhachary GR, Zager JS, Zhen WK, Bergman MA, Freedman-Cass DA, National Comprehensive Cancer Network (2014). Occult primary, version 3.2014. J Natl Compr Canc Netw, 12(7), 969-74.
  15. Garrido-Laguna I, McGregor KA, Wade M, Weis J, Gilcrease W, Burr L, Soldi R, Jakubowski L, Davidson C, Morrell G, Olpin JD, Boucher K, Jones D, Sharma S (2013). A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer. Invest New Drugs, 31(5), 1257-64.
  16. Kimura BJ, Gilcrease GW 3rd, Showalter BK, Phan JN, Wolfson T (2012). Diagnostic performance of a pocket-sized ultrasound device for quick-look cardiac imaging. Am J Emerg Med, 30(1), 32-6.
  17. Kimura BJ, Dalugdugan R, Gilcrease GW 3rd, Phan JN, Showalter BK, Wolfson T (2011). The effect of breathing manner on inferior vena caval diameter. Eur J Echocardiogr, 12(2), 120-3.
  18. Gilcrease GW, Stein JB (2010). A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol, 21(6), 708-11.

Case Report

  1. Nelson KL, Stenehjem D, Driscoll M, Gilcrease GW (2017). Fatal Statin-Induced Rhabdomyolysis by Possible Interaction with Palbociclib. Front Oncol, 7, 150.

Other

  1. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2025). Author Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med (31(6), p. 2069). United States.
  2. Kinsey CG, Camolotto SA, Boespflug AM, Guillen KP, Foth M, Truong A, Schuman SS, Shea JE, Seipp MT, Yap JT, Burrell LD, Lum DH, Whisenant JR, Gilcrease GW 3rd, Cavalieri CC, Rehbein KM, Cutler SL, Affolter KE, Welm AL, Welm BE, Scaife CL, Snyder EL, McMahon M (2019). Publisher Correction: Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nat Med (25(5), p. 861). United States.